Retour
Fourchette du Jour
72,00 €
79,01 €
Fourchette 52 Semaines
61,96 €
138,70 €
Volume
224 285
Moyenne 50J / 200J
82,07 €
/
90,49 €
Clôture Précédente
79,59 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 456,8 | 0,3 |
| P/B | 7,1 | 2,9 |
| ROE % | 2,3 | 3,7 |
| Net Margin % | 2,4 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
130,33 €
+75.9%
Low: 110,00 €
High: 150,00 €
P/E Prévisionnel
169,9
BPA Prévisionnel
0,47 €
Croissance BPA (est.)
+0,0%
CA Est.
440 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,27 €
1,23 € – 1,30 €
|
810 M | 1 |
| FY2029 |
1,89 €
1,83 € – 1,94 €
|
790 M | 1 |
| FY2028 |
1,59 €
0,71 € – 2,66 €
|
720 M | 5 |
Points Clés
ROE of 2,30% is below average
Debt/Equity of 0,23 — conservative balance sheet
Generating 15,71M in free cash flow
P/E of 456,82 — premium valuation
Cash machine — converts 210,81% of earnings into free cash flow
Capital efficient — spends only 2,91% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)99,97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
2,30%
ROIC2,04%
Net Margin2,44%
Op. Margin5,25%
Sécurité
Debt / Equity
0,23
Current Ratio11,69
Interest Coverage168,66
Valorisation
P/E Ratio
456,82
P/B Ratio7,09
EV/EBITDA188,36
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 99,97% | Revenue Growth (3Y) | 106,24% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 305,11M | Net Income (TTM) | 7,45M |
| ROE | 2,30% | ROA | 1,18% |
| Gross Margin | 68,32% | Operating Margin | 5,25% |
| Net Margin | 2,44% | Free Cash Flow (TTM) | 15,71M |
| ROIC | 2,04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,23 | Current Ratio | 11,69 |
| Interest Coverage | 168,66 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 456,82 | P/B Ratio | 7,09 |
| P/S Ratio | 11,16 | PEG Ratio | -4,71 |
| EV/EBITDA | 188,36 | Dividend Yield | 0,00% |
| Market Cap | 3,41B | Enterprise Value | 3,02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 305,11M | 152,58M | 71,73M |
| Net Income | 7,45M | -41,57M | -82,68M |
| EPS (Diluted) | 0,06 | -0,93 | -1,85 |
| Gross Profit | 208,46M | 80,92M | 17,31M |
| Operating Income | 16,02M | -47,15M | -69,50M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 632,65M | 302,06M | 191,68M |
| Total Liabilities | 152,55M | 134,31M | 161,20M |
| Shareholders' Equity | 480,11M | 167,75M | 30,47M |
| Total Debt | 108,90M | 109,38M | 146,35M |
| Cash & Equivalents | 495,98M | 191,48M | 97,27M |
| Current Assets | 560,56M | 227,82M | 115,50M |
| Current Liabilities | 47,96M | 28,39M | 66,80M |